Both in Blank Checks
Translational Development Acquisition vs Gesher Acquisition Corp. II
Over the past year TDAC returned +4.4% and GSHR returned +3.7%; their daily moves had a correlation of 0.06.
TDAC +4.4% GSHR +3.7%Growth of $1, one year, split-adjusted
| Metric | TDAC | GSHR |
|---|---|---|
| Price | $10.91 | $10.63 |
| Market cap | $210.7M | $217.4M |
| Today | +0.46% | +0.09% |
| 1 month | +0.8% | +0.6% |
| 6 months | +2.5% | — |
| Year to date | +4.0% | +3.5% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 38.1× | — |
| Price / sales | — | — |
| Net cash | -$1.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 2.7% | 2.7% |
| Short % of float | 0.0% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).